Search research articles
Contact Us
Filters
Showing results (111-120 of 173) with videos related to
Page
of 18
Sort By:
Cellular Oncology (Dordrecht, Netherlands)
|
April 29, 2026
Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation
Juan Ge, Yongfei Chen, Zongru Jiang, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 16, 2012
Multiple organ dysfunction: a delayed envenomation syndrome caused by tentacle extract from the jellyfish Cyanea capillata
Beilei Wang, Lin Zhang, Jiemin Zheng, et al.
Nature Nanotechnology
|
July 25, 2024
Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells
Jialu Xu, Yue Yu, Yue Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
October 4, 2022
Engineered Extracellular Vesicles with SHP2 High Expression Promote Mitophagy for Alzheimer's Disease Treatment
Fang Xu, Yi Wu, Qianyu Yang, et al.
Journal of Medicinal Chemistry
|
October 13, 2025
Discovery of Novel Purine Derivatives as Potent and Orally Bioavailable PGK1 Inhibitors for the Treatment of Inflammatory Bowel Disease
Zhi Huang, Juan Ge, Yongfei Chen, et al.
The EMBO Journal
|
October 7, 2010
Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90
Shan Yan, Xuxu Sun, Binggang Xiang, et al.
Journal of Medicinal Chemistry
|
August 20, 2024
Discovery of Pyrazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors
Chun Wang, Fengming Zou, Ziping Qi, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic Malignancies
Chenliang Shi, Yun Wu, Fengming Zou, et al.
Journal of Medicinal Chemistry
|
October 13, 2025
Discovery of a 1<i>H</i>-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease
Qiangqiang Tao, Xixiang Li, Hongwei Yu, et al.
ACS Chemical Biology
|
May 19, 2025
Discovery of IHMT-15130 as a Highly Potent Irreversible BMX Inhibitor for the Treatment of Myocardial Hypertrophy and Remodeling
Shuang Qi, Jiangyan Cao, Ting Wu, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 173) with videos related to
Sort By:
Page
of 18
Cellular Oncology (Dordrecht, Netherlands)
|
April 29, 2026
Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation
Juan Ge, Yongfei Chen, Zongru Jiang, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 16, 2012
Multiple organ dysfunction: a delayed envenomation syndrome caused by tentacle extract from the jellyfish Cyanea capillata
Beilei Wang, Lin Zhang, Jiemin Zheng, et al.
Nature Nanotechnology
|
July 25, 2024
Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells
Jialu Xu, Yue Yu, Yue Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
October 4, 2022
Engineered Extracellular Vesicles with SHP2 High Expression Promote Mitophagy for Alzheimer's Disease Treatment
Fang Xu, Yi Wu, Qianyu Yang, et al.
Journal of Medicinal Chemistry
|
October 13, 2025
Discovery of Novel Purine Derivatives as Potent and Orally Bioavailable PGK1 Inhibitors for the Treatment of Inflammatory Bowel Disease
Zhi Huang, Juan Ge, Yongfei Chen, et al.
The EMBO Journal
|
October 7, 2010
Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90
Shan Yan, Xuxu Sun, Binggang Xiang, et al.
Journal of Medicinal Chemistry
|
August 20, 2024
Discovery of Pyrazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors
Chun Wang, Fengming Zou, Ziping Qi, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic Malignancies
Chenliang Shi, Yun Wu, Fengming Zou, et al.
Journal of Medicinal Chemistry
|
October 13, 2025
Discovery of a 1<i>H</i>-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease
Qiangqiang Tao, Xixiang Li, Hongwei Yu, et al.
ACS Chemical Biology
|
May 19, 2025
Discovery of IHMT-15130 as a Highly Potent Irreversible BMX Inhibitor for the Treatment of Myocardial Hypertrophy and Remodeling
Shuang Qi, Jiangyan Cao, Ting Wu, et al.
Page
of 18